Please login to the form below

Not currently logged in
Email:
Password:

Abcam appoints Alan Hirzel as chief executive officer

Promoted from chief marketing officer

edit-alan-hirzelAbcam has appointed Alan Hirzel as its new chief executive officer, taking over from co-founder Jonathan Milner.

Over the past year he has held the position of chief marketing officer at Abcam, a protein research tools and services company. In this role he had responsibility for the company's branding, product portfolio and online consumer offering and worked closely with Milner to develop their strategic vision.

Hirzel said: “I am delighted to be taking on the role of chief executive officer of Abcam at such an exciting point in its growth. I am driven by our mission to help life science researchers discover more and am looking forward to continuing to implement our strategy of driving growth by placing the customer at the heart of the business – a strategy that is already delivering results.”

Milner will continue to play an active role in the company as deputy chairman and remains Abcam's largest shareholder.

He commented: “Whilst I am standing down as chief executive officer, I remain fully committed to this business. I have worked closely with Alan over the last year and he has been inspirational in the evolution of our strategy. 

“Alan has my full confidence and I believe there is no one better to take the company forward on the next phase of our journey.”

23rd September 2014

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics